Dr. Jeffrey Schaffel, MD

NPI: 1174527071
Total Payments
$143.95
2019 Payments
$14.54
Companies
6
Transactions
9

Payment Breakdown by Category

Food & Beverage$143.95 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $143.95 9 100.0%

Top Paying Companies

Company Total Records Latest Year
Valeant Pharmaceuticals North America LLC $39.92 2 $0 (2017)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $39.52 2 $0 (2018)
Janssen Biotech, Inc. $23.87 2 $0 (2018)
NeoTract Inc. $14.54 1 $0 (2019)
Intercept Pharmaceuticals, Inc. $13.75 1 $0 (2018)
Daiichi Sankyo Inc. $12.35 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2019 $14.54 1 NeoTract Inc. ($14.54)
2018 $63.76 4 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.52)
2017 $65.65 4 Valeant Pharmaceuticals North America LLC ($39.92)

All Payment Transactions

9 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/31/2019 NeoTract Inc. UroLift (Device) Food and Beverage In-kind items and services $14.54 General
Category: Interventional Urology
05/31/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), XIFAXAN Food and Beverage In-kind items and services $14.78 General
Category: GASTROENTEROLOGY
05/21/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFIXAN (Drug) Food and Beverage In-kind items and services $24.74 General
Category: GASTROENTEROLOGY
05/08/2018 Janssen Biotech, Inc. REMICADE (Biological), STELARA, SIMPONI Food and Beverage In-kind items and services $10.49 General
Category: Immunology
03/07/2018 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $13.75 General
Category: HEPATOLOGY GASTROENTEROLOGY
07/19/2017 Valeant Pharmaceuticals North America LLC XIFIXAN (Drug) Food and Beverage In-kind items and services $26.17 General
Category: GASTROENTEROLOGY
05/10/2017 Valeant Pharmaceuticals North America LLC RELISTOR (Drug), XIFAXAN Food and Beverage In-kind items and services $13.75 General
Category: GASTROENTEROLOGY
02/23/2017 Janssen Biotech, Inc. STELARA (Biological), REMICADE, SIMPONI Food and Beverage In-kind items and services $13.38 General
Category: Immunology
02/21/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $12.35 General
Category: Opioid Induced Constipation

About Dr. Jeffrey Schaffel, MD

Dr. Jeffrey Schaffel, MD is a Pain Medicine healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174527071.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Schaffel, MD has received a total of $143.95 in payments from pharmaceutical and medical device companies, with $14.54 received in 2019. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($143.95).

Practice Information

  • Specialty Pain Medicine
  • Other Specialties Anesthesiology
  • Location Syracuse, NY
  • Active Since 06/08/2005
  • Last Updated 05/10/2020
  • Taxonomy Code 207LP2900X
  • Entity Type Individual
  • NPI Number 1174527071

Products in Payments

  • XIFIXAN (Drug) $50.91
  • RELISTOR (Drug) $28.53
  • UroLift (Device) $14.54
  • OCALIVA (Drug) $13.75
  • STELARA (Biological) $13.38
  • Movantik (Drug) $12.35
  • REMICADE (Biological) $10.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Syracuse